QUEST DIAGNOSTICS (QDI MU) stock market data APIs
€155.3857
0(0%)
as of September 15, 2025
Try our APIs with
free plan!
QUEST DIAGNOSTICS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for QDI.MU.
Prev. Close
155.3857
Open
155.3857
High
155.3857
Low
155.3857
52 wk Range
132.2225-166.5879
Market Cap
17 386 M
Dividends (Yield)
0.0149
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get QUEST DIAGNOSTICS data using free add-ons & libraries
Get QUEST DIAGNOSTICS Fundamental Data
QUEST DIAGNOSTICS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
QUEST DIAGNOSTICS News
New
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
The Cancerguard test kit Only MCED test on-market to analyze multiple biomarker classes, enhancing early cancer detection Offered as a laboratory-developed test at $689 Nationwide access enabled th...
Quest Diagnostics (DGX): Assessing Valuation Following Launch of Nationwide Pharmacogenomic Test for Precision Medicine
Quest Diagnostics (DGX) recently caught the market’s eye with the launch of an advanced pharmacogenomic laboratory test. The new test aims to help healthcare providers personalize drug therapies bas...
3 Reasons to Sell DGX and 1 Stock to Buy Instead
Even though Quest (currently trading at $183.49 per share) has gained 6% over the last six months, it has lagged the S&P 500’s 15.5% return during that period. This might have investors contemplatin...
Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering
New Service Empowers Clinicians with Personalized Insights from Coriell Life Sciences to Optimize Prescribing Across Specialties SECAUCUS, N.J., Sept. 4, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
